Albemarle Corporation Stock 12‑Month Price Target Cut to $173.29, Implies 66% Upside
Albemarle Corporation's average stock price target was reduced from $174.33 to $173.29 by 17 analysts, with a range of $130 to $225. This implies a 66% upside from the Oct. 2 closing price. The consensus rating remains 'Buy' among 22 analysts, with 14 Buys, 8 Holds, and 0 Sells.
How this was made
The 30-second read
Why it matters
The target reduction may trigger short‑term selling pressure but does not reflect a fundamental shift.
Market read
Analyst target adjustments are a routine data point with limited trading impact.
What to watch
Potential upside from upcoming lithium demand growth and any new supply contracts not reflected in the target.
Background
Albemarle is a leading lithium producer; analyst price targets influence short‑term sentiment.
Ticker impact
Analyst consensus price target for Albemarle was lowered to $173.29 from $174.33, indicating a fresh downgrade.
likely pressure as the market prices in the lower target
Analyst target reductions typically precede modest price declines.
Market effects
Minor impact on the specialty chemicals sector as Albemarle is a major lithium producer.
Limited to U.S. investors tracking lithium and battery supply chains.
Low; price target changes affect only Albemarle shareholders.
Counterpoint
Some investors may view the modest cut as a buying opportunity if they believe lithium demand remains strong.
Key entities
- CompanyAlbemarle Corporation
U.S. specialty chemicals and lithium producer.
